MedElevator
Войти в исследования Preventive medicine · 2026
Combined effects of smoking and hormonal contraceptives in the occurrence of inflammatory bowel disease - A weighted Cox analysis in a nested case-control study in Quebec, Canada.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fantodji Canisius, Rousseau Marie-Claude, Nicolau Belinda, Madathil Sreenath, Benedetti Andrea, Jantchou Prévost
Аннотация
OBJECTIVE: Hormonal contraceptives increase nicotine absorption. Their joint effect with smoking on inflammatory bowel disease remains unclear. We assessed independent and joint associations of smoking and hormonal contraception with Crohn's disease and ulcerative colitis.
METHODS: In 2021, we conducted a nested case-control study with cumulative sampling of controls, in Quebec, Canada. Cases were identified with health services-based validated algorithms. Smoking, hormonal contraception, and covariates were self-reported. Time-dependent exposures were analyzed in 2024 using weighted Cox models to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) and assess additive and multiplicative interactions.
RESULTS: The study included 1718 women (591 controls, 790 Crohn's disease, 337 ulcerative colitis cases). Compared with non-smokers non-users of hormonal contraception, former smokers using hormonal contraceptives had increased Crohn's disease (HR = 2.45; 95% CI: 1.51, 3.96) and ulcerative colitis risks (HR = 2.88; 95% CI: 1.65, 5.02). Current smokers using hormonal contraceptives had elevated risks of Crohn's disease (HR = 2.62; 95% CI: 1.93, 3.56) but not ulcerative colitis (HR = 0.72; 95% CI: 0.42, 1.17). A negative additive interaction was observed for ulcerative colitis with no multiplicative interactions.
CONCLUSIONS: Smoking and hormonal contraception are independently associated with Crohn's disease, but not ulcerative colitis, with implications for inflammatory bowel disease risk assessment in women.
METHODS: In 2021, we conducted a nested case-control study with cumulative sampling of controls, in Quebec, Canada. Cases were identified with health services-based validated algorithms. Smoking, hormonal contraception, and covariates were self-reported. Time-dependent exposures were analyzed in 2024 using weighted Cox models to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) and assess additive and multiplicative interactions.
RESULTS: The study included 1718 women (591 controls, 790 Crohn's disease, 337 ulcerative colitis cases). Compared with non-smokers non-users of hormonal contraception, former smokers using hormonal contraceptives had increased Crohn's disease (HR = 2.45; 95% CI: 1.51, 3.96) and ulcerative colitis risks (HR = 2.88; 95% CI: 1.65, 5.02). Current smokers using hormonal contraceptives had elevated risks of Crohn's disease (HR = 2.62; 95% CI: 1.93, 3.56) but not ulcerative colitis (HR = 0.72; 95% CI: 0.42, 1.17). A negative additive interaction was observed for ulcerative colitis with no multiplicative interactions.
CONCLUSIONS: Smoking and hormonal contraception are independently associated with Crohn's disease, but not ulcerative colitis, with implications for inflammatory bowel disease risk assessment in women.